What is the official website of LGC Clinical Diagnostics ?

The official website of LGC Clinical Diagnostics is https://lgcclinicaldiagnostics.com.

What is LGC Clinical Diagnostics's cybersecurity risk score?

LGC Clinical Diagnostics has an AI-generated cybersecurity risk score of 756 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has LGC Clinical Diagnostics experienced?

According to Rankiteo, LGC Clinical Diagnostics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has LGC Clinical Diagnostics been affected by any supply chain cyber incidents ?

According to Rankiteo, LGC Clinical Diagnostics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does LGC Clinical Diagnostics have SOC 2 Type 1 certification ?

According to Rankiteo, LGC Clinical Diagnostics is not certified under SOC 2 Type 1.

Does LGC Clinical Diagnostics have SOC 2 Type 2 certification ?

According to Rankiteo, LGC Clinical Diagnostics does not hold a SOC 2 Type 2 certification.

Does LGC Clinical Diagnostics comply with GDPR ?

According to Rankiteo, LGC Clinical Diagnostics is not listed as GDPR compliant.

Does LGC Clinical Diagnostics have PCI DSS certification ?

According to Rankiteo, LGC Clinical Diagnostics does not currently maintain PCI DSS compliance.

Does LGC Clinical Diagnostics comply with HIPAA ?

According to Rankiteo, LGC Clinical Diagnostics is not compliant with HIPAA regulations.

Does LGC Clinical Diagnostics have ISO 27001 certification ?

According to Rankiteo,LGC Clinical Diagnostics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does LGC Clinical Diagnostics operate in ?

LGC Clinical Diagnostics operates primarily in the Biotechnology industry.

How many employees does LGC Clinical Diagnostics have ?

LGC Clinical Diagnostics employs approximately 226 people worldwide.

Does LGC Clinical Diagnostics own any subsidiaries ?

LGC Clinical Diagnostics presently has no subsidiaries across any sectors.

How many LinkedIn followers does LGC Clinical Diagnostics have ?

LGC Clinical Diagnostics's official LinkedIn profile has approximately 4,678 followers.

Does LGC Clinical Diagnostics have a Crunchbase profile ?

No, LGC Clinical Diagnostics does not have a profile on Crunchbase.

Does LGC Clinical Diagnostics have a LinkedIn profile ?

Yes, LGC Clinical Diagnostics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/lgc-clinical-diagnostics.

How many cybersecurity incidents has LGC Clinical Diagnostics experienced ?

As of August 31, 2026, Rankiteo reports that LGC Clinical Diagnostics has not experienced any cybersecurity incidents.

How many peer or competitor companies does LGC Clinical Diagnostics have ?

LGC Clinical Diagnostics has an estimated 1,078 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

LCD

Boost Score +25 with badge (5 left)

756

/1000

Fair

781

/1000

Fair

LGC Clinical Diagnostics Vendor Cyber Rating & Cyber Score

lgcclinicaldiagnostics.com

Add Your Compliance Badge

LGC Clinical Diagnostics develops and manufactures a comprehensive portfolio of catalog and custom-developed diagnostic quality solutions, biological and reagent component materials for the extended life sciences industry. Our scientific expertise, together with our custom product development capabilities, further accelerates bringing your innovations to life. Together, we are changing the future of diagnostics. LGC Clinical Diagnostics has over 35 years of experience as a leading and trusted global manufacturer of Quality Management Tools (QMT) and reagent components. We partner with In Vitro Diagnostics (IVD) and biopharmaceutical developers, clinical research organizations (CROs) and academic institutions in commercialization

LCD A.I CyberSecurity Scoring

Scoring History

LCD

LGC Clinical Diagnostics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

LCD Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for LCD

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for LGC Clinical Diagnostics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for LGC Clinical Diagnostics in 2026.

Incident Types LCD vs Biotechnology Industry Avg (This Year)

No incidents recorded for LGC Clinical Diagnostics in 2026.

Incident History - LCD (X = Date, Y = Severity)

Loading…

SUBSIDIARY

LGC Clinical Diagnostics Subsidiaries

Parent Company

LCD

Biotechnology

Website: https://lgcclinicaldiagnostics.com

Company Size: 226

No subsidiary data available for this company.

Loading…

LGC Clinical Diagnostics Similar Companies

Regeneron

cb regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

LGC Clinical Diagnostics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-82592

SUMMARY

A vulnerability was detected in D-Link DIR-825M 1.1.8. This affects the function sub_46725C of the file /boafrm/formDiskFormat of the component Disk Formatting Handler Endpoint. The manipulation of the argument partition results in stack-based buffer overflow. The attack can be executed remotely. The exploit is now public and may be used.

Published

Date2026-08-30

Updated

Date2026-08-30

RISK INFORMATION (Score: 9.9)

cvss2

Base Score: 9.0

Complexity: LOW

AV:N/AC:L/Au:S/C:C/I:C/A:C

cvss3

Base Score: 9.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.1

REFERENCES

CVE-2026-82591

SUMMARY

A security vulnerability has been detected in Open Asset Import Library Assimp up to 6.0.2. The impacted element is the function MD5Importer::MakeDataUnique of the file code/AssetLib/MD5/MD5Loader.cpp. The manipulation of the argument iNewIndex leads to heap-based buffer overflow. The attack can only be performed from a local environment. The identifier of the patch is bf9dabb617c46e5133dac65cca6bff177917afcb. Applying a patch is the recommended action to fix this issue.

Published

Date2026-08-30

Updated

Date2026-08-30

RISK INFORMATION (Score: 5.3)

cvss2

Base Score: 4.3

Complexity: LOW

AV:L/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 5.3

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 4.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

1.8

REFERENCES

CVE-2026-82590

SUMMARY

A weakness has been identified in Open5GS up to 2.7.7. The affected element is the function smf_nudm_sdm_handle_get of the file src/smf/nudm-handler.c of the component SMF. Executing a manipulation of the argument preemptCap can lead to reachable assertion. The attack may be launched remotely. Upgrading to version 2.8.0 is sufficient to fix this issue. This patch is called 4554405f29bffd7562abedbee63484825bd90cd5. You should upgrade the affected component.

Published

Date2026-08-30

Updated

Date2026-08-30

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-82589

SUMMARY

A security flaw has been discovered in Open5GS up to 2.7.7. Impacted is the function amf_namf_comm_handle_n1_n2_message_transfer of the file src/amf/namf-handler.c of the component N1-N2 Message Handler. Performing a manipulation of the argument N1N2MessageTransferReqData.n2InfoContainer.smInfo.n2InfoContent.ngapIeType results in denial of service. The attack may be initiated remotely. The exploit has been released to the public and may be used for attacks. Upgrading to version 2.8.0 is recommended to address this issue. The patch is named abf8a836564b966b5141110fc25ed413c4f17522. It is advisable to upgrade the affected component.

Published

Date2026-08-30

Updated

Date2026-08-30

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-82588

SUMMARY

A vulnerability was identified in Open5GS up to 2.7.7. This issue affects some unknown processing of the file src/amf/namf-handler.c of the component Transfer Endpoint. Such manipulation leads to null pointer dereference. The attack can be launched remotely. Upgrading to version 2.8.0 is capable of addressing this issue. The name of the patch is abf8a836564b966b5141110fc25ed413c4f17522. Upgrading the affected component is advised.

Published

Date2026-08-30

Updated

Date2026-08-30

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:N/I:N/A:P

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:N/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…